Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Jan 2017

Tang Wenbin, Ren Aimin, Xiao Hongyang, Sun Huizhen, Li Bin

Abstract excerpt

Neurensin-2 (NRSN2) is a 24KD protein, which is reported located in the membrane, while its biological functions remain unknown, not to mention in the field of tumor biology. In current study, we aimed to analyze the functions of NRSN2 in ovarian cancer. We screened TCGA database and surprisingly found that its copy number and mRNA level are gained and heightened respectively in parts of serous ovarian cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Cisplatin
Share to Extracellular Signal-Regulated MAP Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Invasiveness

Share to Neoplastic Stem Cells

Share to Paclitaxel

Share to Proto-Oncogene Proteins c-akt

Share to Twist-Related Protein 1

Source

Identifiers

PMID: 27908706
DOI: 10.1016/j.biopha.2016.11.012

Genes

NRSN2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer.PMID 27908706Read ↗

Upregulation of NEK2 is associated with drug resistance in ovarian cancerSemantic proximity Read ↗

TCGA and Experimental Validation-Based Analysis of the SPRR2A Gene's Expression and Clinical Relevance in Endometrial CancerSemantic proximity Read ↗

PSMC2/CCND1 axis promotes development of ovarian cancer through regulating cell growth, apoptosis and migrationSemantic proximity Read ↗

Aberrant high expression level of MORC2 is a common character in multiple cancersSemantic proximity Read ↗

Clinical Relevance and Prognostic Value of the Neuronal Protein Neuroligin 2 in Breast CancerSemantic proximity Read ↗

Decreased EMILIN2 correlates to metabolism phenotype and poor prognosis of ovarian cancer.Semantic proximity Read ↗

Expression pattern of human SERPINE2 in a variety of human tumorsSemantic proximity Read ↗

Evaluating trophinin associated protein as a biomarker of prognosis and therapy response in renal cell carcinoma.Semantic proximity Read ↗

SLC11A2: a promising biomarker and therapeutic target in ovarian cancerSemantic proximity Read ↗

Neuropilin-2 and Its Transcript Variants Correlate with Clinical Outcome in Bladder Cancer.Semantic proximity Read ↗

TROP2 represents a negative prognostic factor in colorectal adenocarcinoma and its expression is associated with features of epithelial-mesenchymal transition and invasivenessSemantic proximity Read ↗

Pan-cancer analysis reveals that nischarin may not be the universal tumor suppressorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.